miR-150 Promotes Human Breast Cancer Growth and Malignant Behavior by Targeting the Pro-Apoptotic Purinergic P2X7 Receptor
暂无分享,去创建一个
Wei Wu | Ling Lin | F. Su | Ling Lin | Wei Wu | Jia-ning Chen | Yandan Yao | Hongyu Li | Songyin Huang | Xiaoqiang Liu | Fengxi Su | Yandan Yao | Jianing Chen | Songyin Huang | Yongsong Chen | Nengyong Ouyang | Hongyu Li | Xiaoqiang Liu | Yongsong Chen | Neng-yong Ouyang | Jianing Chen
[1] G. MacLennan,et al. P2X7 receptor expression is decreased in epithelial cancer cells of ectodermal, uro-genital sinus, and distal paramesonephric duct origin , 2009, Purinergic Signalling.
[2] Sumit Arora,et al. MicroRNA-150 directly targets MUC4 and suppresses growth and malignant behavior of pancreatic cancer cells. , 2011, Carcinogenesis.
[3] M. Gavala,et al. Mutation of putative N-linked glycosylation sites on the human nucleotide receptor P2X7 reveals a key residue important for receptor function. , 2010, Biochemistry.
[4] J. Li,et al. MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1 , 2012, Oncogene.
[5] Yang Wang,et al. Regulation of lung surfactant secretion by microRNA-150. , 2012, Biochemical and biophysical research communications.
[6] J. Egido,et al. Atorvastatin reduces NF-kappaB activation and chemokine expression in vascular smooth muscle cells and mononuclear cells. , 1999, Atherosclerosis.
[7] S. Layé,et al. Impaired Interleukin-1β and c-Fos Expression in the Hippocampus Is Associated with a Spatial Memory Deficit in P2X7 Receptor-Deficient Mice , 2009, PloS one.
[8] F. Di Virgilio,et al. P2X7: a growth-promoting receptor—implications for cancer , 2009, Purinergic Signalling.
[9] F. Abdul-Karim,et al. The P2X7 Receptor: A Novel Biomarker of Uterine Epithelial Cancers , 2006, Cancer Epidemiology Biomarkers & Prevention.
[10] J. Potashkin,et al. Decreased expression of P2X7 in endometrial epithelial pre-cancerous and cancer cells. , 2007, Gynecologic oncology.
[11] B. Zhivotovsky,et al. Role of alterations in the apoptotic machinery in sensitivity of cancer cells to treatment. , 2006, Current pharmaceutical design.
[12] Haihua Gu,et al. Abstract P5-10-06: A functional role for miR-150 in breast cancer , 2012 .
[13] T. Prolla,et al. Mitochondrial DNA mutations and apoptosis in mammalian aging. , 2006, Cancer research.
[14] I. Chessell,et al. The role of P2X7 in pain and inflammation , 2007, Purinergic Signalling.
[15] H. Tagawa,et al. The role of microRNA-150 as a tumor suppressor in malignant lymphoma , 2011, Leukemia.
[16] Chang Gong,et al. Up-regulation of miR-21 Mediates Resistance to Trastuzumab Therapy for Breast Cancer* , 2011, The Journal of Biological Chemistry.
[17] Lin He,et al. MicroRNAs: small RNAs with a big role in gene regulation , 2004, Nature Reviews Genetics.
[18] H. Iwase,et al. [Breast cancer]. , 2006, Nihon rinsho. Japanese journal of clinical medicine.
[19] L. Luo,et al. Regulation of P2X7 gene transcription , 2009, Purinergic Signalling.
[20] Robert A. Weinberg,et al. Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model , 2010, Nature Biotechnology.
[21] Shangqin Guo,et al. MicroRNA-mediated control of cell fate in megakaryocyte-erythrocyte progenitors. , 2008, Developmental cell.
[22] Péter Csermely,et al. Apoptosis, necrosis and cellular senescence: chaperone occupancy as a potential switch , 2003, Aging cell.
[23] Kai Li,et al. MiR-150 promotes gastric cancer proliferation by negatively regulating the pro-apoptotic gene EGR2. , 2010, Biochemical and biophysical research communications.
[24] A. Armugam,et al. MicroRNAs as therapeutic targets in human diseases , 2007, Expert opinion on therapeutic targets.
[25] Christopher S. Stevenson,et al. P2X7 Receptor and Caspase 1 Activation Are Central to Airway Inflammation Observed after Exposure to Tobacco Smoke , 2011, PloS one.
[26] A. van den Berg,et al. miRNA analysis in B‐cell chronic lymphocytic leukaemia: proliferation centres characterized by low miR‐150 and high BIC/miR‐155 expression , 2008, The Journal of pathology.
[27] Carlos Agustí,et al. MicroRNAs Expressed during Lung Cancer Development Are Expressed in Human Pseudoglandular Lung Embryogenesis , 2009, Oncology.
[28] J. Potashkin,et al. MicroRNAs miR-186 and miR-150 Down-regulate Expression of the Pro-apoptotic Purinergic P2X7 Receptor by Activation of Instability Sites at the 3′-Untranslated Region of the Gene That Decrease Steady-state Levels of the Transcript* , 2008, Journal of Biological Chemistry.
[29] Debmalya Barh,et al. Let-7, miR-125, miR-205, and miR-296 are prospective therapeutic agents in breast cancer molecular medicine , 2008 .
[30] Ha Won Kim,et al. microRNA-150 Regulates Mobilization and Migration of Bone Marrow-Derived Mononuclear Cells by Targeting Cxcr4 , 2011, PloS one.
[31] A. Navarro,et al. MicroRNAs in Human Embryonic and Cancer Stem Cells , 2010, Yonsei medical journal.
[32] Zun-Ling Li,et al. Regulating A549 cells growth by ASO inhibiting miRNA expression , 2010, Molecular and Cellular Biochemistry.
[33] Liqin Wang,et al. A Truncated P2X7 Receptor Variant (P2X7-j) Endogenously Expressed in Cervical Cancer Cells Antagonizes the Full-length P2X7 Receptor through Hetero-oligomerization* , 2006, Journal of Biological Chemistry.
[34] Charles D. Johnson,et al. Genome-scale microRNA and small interfering RNA screens identify small RNA modulators of TRAIL-induced apoptosis pathway. , 2007, Cancer research.
[35] Catalin Vasilescu,et al. MicroRNA Fingerprints Identify miR-150 as a Plasma Prognostic Marker in Patients with Sepsis , 2009, PloS one.
[36] G. Gorodeski. P2X7-mediated chemoprevention of epithelial cancers , 2009, Expert opinion on therapeutic targets.
[37] N. Rajewsky,et al. Silencing of microRNAs in vivo with ‘antagomirs’ , 2005, Nature.
[38] Robert A. Weinberg,et al. A Pleiotropically Acting MicroRNA, miR-31, Inhibits Breast Cancer Metastasis , 2009 .
[39] H. Kuo,et al. c-Myb is an evolutionary conserved miR-150 target and miR-150/c-Myb interaction is important for embryonic development. , 2008, Molecular biology and evolution.
[40] C. Mayr,et al. miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely , 2007, Proceedings of the National Academy of Sciences.